BDTX
Price
$2.36
Change
-$0.10 (-4.07%)
Updated
Jun 27 closing price
Capitalization
133.63M
43 days until earnings call
ERNA
Price
$1.85
Change
-$0.05 (-2.63%)
Updated
Jun 27 closing price
Capitalization
13.68M
Interact to see
Advertisement

BDTX vs ERNA

Header iconBDTX vs ERNA Comparison
Open Charts BDTX vs ERNABanner chart's image
Black Diamond Therapeutics
Price$2.36
Change-$0.10 (-4.07%)
Volume$6.07M
Capitalization133.63M
Ernexa Therapeutics
Price$1.85
Change-$0.05 (-2.63%)
Volume$9.34K
Capitalization13.68M
BDTX vs ERNA Comparison Chart in %
Loading...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ERNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDTX vs. ERNA commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Buy and ERNA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BDTX: $2.36 vs. ERNA: $1.85)
Brand notoriety: BDTX and ERNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 503% vs. ERNA: 15%
Market capitalization -- BDTX: $133.63M vs. ERNA: $13.62M
BDTX [@Biotechnology] is valued at $133.63M. ERNA’s [@Biotechnology] market capitalization is $13.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 1 FA rating(s) are green whileERNA’s FA Score has 0 green FA rating(s).

  • BDTX’s FA Score: 1 green, 4 red.
  • ERNA’s FA Score: 0 green, 5 red.
According to our system of comparison, BDTX is a better buy in the long-term than ERNA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 2 TA indicator(s) are bullish while ERNA’s TA Score has 4 bullish TA indicator(s).

  • BDTX’s TA Score: 2 bullish, 5 bearish.
  • ERNA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ERNA is a better buy in the short-term than BDTX.

Price Growth

BDTX (@Biotechnology) experienced а +1.29% price change this week, while ERNA (@Biotechnology) price change was -24.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BDTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDTX($134M) has a higher market cap than ERNA($13.7M). BDTX YTD gains are higher at: 10.280 vs. ERNA (-58.050). BDTX has more cash in the bank: 152M vs. ERNA (1.92M). ERNA has less debt than BDTX: ERNA (2.88M) vs BDTX (21.6M).
BDTXERNABDTX / ERNA
Capitalization134M13.7M978%
EBITDA-3.66MN/A-
Gain YTD10.280-58.050-18%
P/E Ratio39.33N/A-
Revenue70MN/A-
Total Cash152M1.92M7,925%
Total Debt21.6M2.88M749%
FUNDAMENTALS RATINGS
ERNA: Fundamental Ratings
ERNA
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
96
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDTXERNA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ERNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARGGY1.140.07
+6.54%
Aston Martin Lagonda Global Holdings plc.
WPFH1.500.05
+3.45%
WPF Holdings, Inc.
RYBIF15.00N/A
N/A
Ryobi Ltd.
KRYAF104.09N/A
N/A
Kerry Group plc
PIAC0.07N/A
N/A
Princeton Capital Corporation

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with CCCC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-4.07%
CCCC - BDTX
50%
Loosely correlated
-7.89%
ATXS - BDTX
49%
Loosely correlated
N/A
BEAM - BDTX
47%
Loosely correlated
-1.98%
RLAY - BDTX
47%
Loosely correlated
-0.60%
IMNM - BDTX
47%
Loosely correlated
-0.23%
More

ERNA and

Correlation & Price change

A.I.dvisor tells us that ERNA and ATOS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ERNA and ATOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ERNA
1D Price
Change %
ERNA100%
-2.63%
ATOS - ERNA
28%
Poorly correlated
+1.64%
RNTX - ERNA
26%
Poorly correlated
-4.55%
BDTX - ERNA
25%
Poorly correlated
-4.07%
VSTM - ERNA
25%
Poorly correlated
-0.24%
RAIN - ERNA
25%
Poorly correlated
+5.79%
More